The effectiveness of quality control samples in pharmaceutical bioanalysis.
QC failure
QCs
bioanalysis
bioanalytical data quality
failed runs
quality controls
repeat runs
sample retesting
Journal
Bioanalysis
ISSN: 1757-6199
Titre abrégé: Bioanalysis
Pays: England
ID NLM: 101512484
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
pubmed:
5
2
2021
medline:
1
9
2021
entrez:
4
2
2021
Statut:
ppublish
Résumé
The use of quality control (QC) samples in bioanalysis is well established and consistent with regulatory guidance. However, a systematic evaluation of whether QC samples serve the intended purpose of improving data quality has not been undertaken. The Translational and ADME Sciences Leadership Group (TALG) of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) conducted an evaluation to assess whether closer agreement is observed when comparing pharmacokinetic data from two passed runs, than when comparing data from failed and passed (retest) runs. Analysis of data collected across organizations, molecular types and analytical platforms, revealed that bioanalytical methods are very reproducible; and that QC samples improve the overall quality of pharmacokinetic concentration data and justifies their continued use.
Identifiants
pubmed: 33538614
doi: 10.4155/bio-2020-0265
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM